androstenedione has been researched along with Pituitary Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arduç, A; Başaran, MN; Berker, D; Dağdelen, I; Doğan, BA; Güler, S; Küçükler, K; Tuna, MM | 1 |
de Lange, WE; Doorenbos, H; Pratt, JJ; Sluiter, WJ | 1 |
Elhaj, GE; Franklin, RR; Leavens, ME; Samaan, NA | 1 |
Aakvaag, A; Eik-Nes, KB; Gautvik, KM; Haug, E; Sunde, A | 1 |
Andó, S; Verdonck, L; Vermeulen, A | 1 |
Burton, S; Klibanski, A; Miller, KK; Schiller, A; Schoenfeld, D; Sesmilo, G | 1 |
Chang, S; Odell, WD; Parker, LN | 1 |
Ahlen, A; Eneroth, P; Gustafsson, JA; Skett, P; Sonnenschein, C; Stenberg, A | 1 |
Aakvaag, A; Haug, E | 1 |
Eneroth, P; Gustafsson, JA; Skett, P; Sonnenschein, C | 1 |
Eneroth, P; Gustafsson, JA; Larsson, A; Skett, P; Sonnenschein, C; Stenberg, A | 1 |
James, VH | 1 |
Ehara, Y; Rebar, R; Siler, T; Vandenberg, G; Yen, SS | 1 |
13 other study(ies) available for androstenedione and Pituitary Neoplasms
Article | Year |
---|---|
Increased Risk of Unfavorable Metabolic Outcome in Patients with Clinically Nonfunctioning Pituitary Adenomas.
Topics: Adenoma; Adult; Androstenedione; Atherosclerosis; Female; Humans; Hyperandrogenism; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Risk | 2015 |
Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyrapone.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Androstenedione; Cortodoxone; Female; Humans; Hydrocortisone; Male; Metyrapone; Middle Aged; Pituitary Neoplasms; Pituitary-Adrenal System; Testosterone; Tetrahydrocortisol; Time Factors | 1980 |
The clinical and biochemical features in 26 patients with prolactinoma before and after transsphenoidal microresection.
Topics: Adenoma; Adolescent; Adult; Androstenedione; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Microsurgery; Pituitary Neoplasms; Pregnancy; Prognosis; Prolactin; Testosterone | 1980 |
Androgen metabolism and mechanism of action in prolactin secreting rat pituitary cells in culture.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstane-3,17-diol; Androstenedione; Animals; Cell Division; Cell Line; Dihydrotestosterone; Estradiol; Estrenes; Metribolone; Pituitary Neoplasms; Prolactin; Rats; Testosterone | 1982 |
Prolactinomas, testosterone-binding globulin, and androgen metabolism.
Topics: Adenoma; Adult; Androgens; Androstenedione; Dihydrotestosterone; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pituitary Neoplasms; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1982 |
Androgen deficiency in women with hypopituitarism.
Topics: Adenoma; Adrenal Insufficiency; Androstenedione; Brain Neoplasms; Dehydroepiandrosterone Sulfate; Estrogen Replacement Therapy; Female; Humans; Hypogonadism; Hypopituitarism; Menstrual Cycle; Middle Aged; Pituitary Neoplasms; Postmenopause; Premenopause; Reference Values; Testosterone | 2001 |
Adrenal androgens in patients with chronic marked elevation of prolactin.
Topics: Androstenedione; Dehydroepiandrosterone; Female; Humans; Hydrocortisone; Male; Pituitary Neoplasms; Prolactin | 1978 |
Evidence for an unidentified factor from the pituitary gland which affects the steroid metabolism in isolated hepatocytes and hepatoma cells of the rat.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Animals; Carcinoma, Hepatocellular; Female; Liver; Liver Neoplasms; Male; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Rats; Steroid Hydroxylases; Tissue Extracts | 1978 |
Metabolism of [3H]-testosterone and [1,2-(3)H]-dihydrotestosterone by prolactin secreting rat pituitary tumour cells in culture.
Topics: Androstane-3,17-diol; Androstenedione; Animals; Cells, Cultured; Dihydrotestosterone; Estradiol; Pituitary Neoplasms; Prolactin; Rats; Testosterone | 1979 |
Changes in hepatic steroid metabolism in rat following transplantation of four different clones of pituitary tumor cells.
Topics: Androstane-3,17-diol; Androstenedione; Animals; Clone Cells; Follicle Stimulating Hormone; Hydroxysteroid Dehydrogenases; Liver; Luteinizing Hormone; Male; Neoplasm Transplantation; Oxidoreductases; Pituitary Neoplasms; Prolactin; Rats; Sex Factors; Steroid Hydroxylases; Steroids | 1977 |
Feminization of hepatic S metabolism in male rats with a transplanted (MtT/F4).
Topics: Androstenedione; Animals; Cell Line; Female; Feminization; Follicle Stimulating Hormone; Kinetics; Liver; Luteinizing Hormone; Male; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Rats; Steroid Hydroxylases | 1976 |
Adrenal steroid endocrinology--some unsolved problems.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Circadian Rhythm; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Hyperprolactinemia; Insulin; Pituitary Neoplasms | 1991 |
Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.
Topics: Adult; Amenorrhea; Androstenedione; Castration; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Feedback; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Half-Life; Humans; Hypogonadism; Hypothalamus; Luteinizing Hormone; Male; Menstruation; Ovary; Pituitary Gland; Pituitary Neoplasms; Radioimmunoassay; Testosterone; Time Factors; Turner Syndrome | 1973 |